Segmed

Overview
Activities
News
Clinical Trial Technology?
Product stageSegments
Expansion
?
Protocol Design and Review
?

Segmed is a cloud-based real-world imaging platform that simplifies access to medical data for healthcare innovation. The company provides a vast repository of diagnostic-grade medical images and clinical data to accelerate research and development in the life sciences and technology industries. Through its self-serve platform, Segmed Insight, researchers and AI developers can search, view, and construct customized datasets from millions of medical imaging studies. The platform allows users to receive data within days, significantly reducing the time traditionally required for data sourcing.

Segmed's technology focuses on aggregating diverse medical data from healthcare systems, hospitals, and imaging clinics across 1,000 locations on five continents. As of August 2023, the company's network exceeded 100 million imaging studies, representing over 40 US states and 15 countries. Segmed employs proprietary algorithms to standardize and de-identify data, ensuring strict compliance with HIPAA and GDPR regulations. The company also maintains SOC2 attestation and achieved ISO 27001 certification in July 2023, further demonstrating its commitment to data security and privacy.

In April 2023, Segmed expanded its offerings to include synthetic medical imaging data through partnerships with NVIDIA and RadImageNet. This synthetic data covers various modalities such as CT, MRI, ultrasound, and endoscopic surgery, with over 160 pathologic classifications. The addition of synthetic data aims to enhance the robustness and adaptability of AI algorithms while maintaining patient privacy. Segmed also collaborates with Datavant to link imaging data with other data types, enriching the real-world imaging data available on its platform.

Key customers and partnerships

Segmed serves pharmaceutical companies, medical device manufacturers, and technology firms in need of longitudinal, practice-diverse, and clinically validated data. The company has forged partnerships with healthcare systems, hospitals, and imaging clinics across 1,000 locations on five continents to aggregate diverse medical data. In April 2023, Segmed announced collaborations with NVIDIA and RadImageNet to offer synthetic medical imaging data via their Segmed Insight platform. This partnership aims to advance medical AI algorithms by expanding the scope and variability of patient datasets for training and validation purposes.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
3790 El Camino Real #81 Palo Alto CA USA
Founded year:
2019
Employees:
11-50
IPO status:
Private
Total funding:
USD 20.4 mn
Last Funding:
USD 10.4 mn (Series A; Sep 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.